Hsa-miR-223-3p targets the EPB41L3, a potential tumor suppressor gene, the NFIX gene that regulates both cell proliferation and migration, the SLC2A4/GLUT4 is a glucose transporter and a biomarker for many types of malignant tumors [43,44,45]. The gene discussed is SLC2A4; the disease is neoplasm.